普罗塔利克斯生物治疗学增加了主要的罗素指数,可能提高了知名度和投资兴趣。 Protalix BioTherapeutics added to key Russell indexes, likely boosting visibility and investment interest.

Protalix 生物治疗公司是一家专门从事治疗性蛋白质生产的生物制药公司,现已加入Russell 3000和2000指数。 Protalix BioTherapeutics, a biopharmaceutical company specializing in therapeutic protein production, has been added to the Russell 3000 and 2000 Indexes. 在对这些指数进行年度重组之后,这一纳入有望提高公司在投资管理人员和机构投资者中的可见度。 This inclusion, following the annual reconstitution of these indexes, is expected to increase the company's visibility among investment managers and institutional investors. Russell指数是广泛使用的基准,有数万亿美元的资产跟踪。 The Russell indexes are widely used benchmarks, with trillions of dollars in assets tracking them.